Contact the Desk

Editorial correspondence

We welcome notes that make the record more accurate: a citation that's been misquoted, a newer study on GHK-Cu or Melanotan II that belongs on the references page, or a regulatory update that changes an approval status described here. The most useful messages name three things — which page, the specific passage, and a DOI or PubMed link for the proposed source — so the change can be checked before anything is edited.

Editorial mailbox: editors@brightpeptides.com

What we can't help with

Because brightpeptides reports the literature rather than practicing medicine or selling anything, we can't weigh in on whether GHK-Cu or Melanotan II is right for a particular person, name a dose or schedule for anyone, or help source either compound from a supplier. Anyone seeking medical guidance should take that question to a licensed clinician in their own jurisdiction. Replies to the mailbox aren't guaranteed and may take a while.